Flare of rheumatoid arthritis after COVID-19 vaccination

KA Terracina, FK Tan - The Lancet Rheumatology, 2021 - thelancet.com
With the COVID-19 pandemic, there has been great uncertainty about whether the virus
could exacerbate autoimmune diseases such as rheumatoid arthritis given that infection can …

[HTML][HTML] Do we miss rare adverse events induced by COVID-19 vaccination?

Z Mohseni Afshar, A Tavakoli Pirzaman, JJ Liang… - Frontiers in …, 2022 - frontiersin.org
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has
caused many complications, the invention of coronavirus disease 2019 (COVID-19) …

[HTML][HTML] Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis

A Rubbert-Roth, N Vuilleumier, B Ludewig… - The Lancet …, 2021 - thelancet.com
1 Kalfaoglu B, Almeida-Santos J, Tye CA, Satou Y, Ono M. T-cell hyperactivation and
paralysis in severe COVID-19 infection revealed by single-cell analysis. Front Immunol …

Vitamins, microelements and the immune system: current standpoint in the fight against coronavirus disease 2019

B Djordjevic, J Milenkovic, D Stojanovic… - British Journal of …, 2022 - cambridge.org
Coronavirus disease 2019 (COVID-19) is an acute respiratory disease associated with
severe systemic inflammation. The optimal status of vitamins and microelements is …

[HTML][HTML] The Fight against COVID-19 on the multi-protease front and surroundings: could an early therapeutic approach with repositioning drugs prevent the disease …

A Vianello, S Del Turco, S Babboni, B Silvestrini… - Biomedicines, 2021 - mdpi.com
The interaction between the membrane spike (S) protein of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the transmembrane angiotensin-converting …

[HTML][HTML] Integration and reanalysis of four RNA-seq datasets including BALF, nasopharyngeal swabs, lung biopsy, and mouse models reveals common immune …

R Alberts, SC Chan, QF Meng, S He, L Rao, X Liu… - Immune …, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2), has spread over the world causing a pandemic …

Construction and Validation of a Novel Immune-Related Gene Pairs-Based Prognostic Model in Lung Adenocarcinoma

Y Liu, J Zhou, J Wu, X Zhang, J Guo, Y Xing… - Cancer …, 2023 - journals.sagepub.com
Object Focus on immune-related gene pairs (IRGPs) and develop a prognostic model to
predict the prognosis of patients with lung adenocarcinoma (LUAD). Methods First, the …

Drug repurposing of dermatologic medications to treat coronavirus disease 2019: Science or fiction?

S Vassileva, V Mateeva, K Drenovska - Clinics in Dermatology, 2021 - Elsevier
No pharmaceutical products have been demonstrated to be safe and effective to specifically
treat coronavirus disease 2019 (COVID-19); therefore, the therapy administered to infected …

Rare adverse events following Covid-19 vaccination: A review

M Barary, ZM Afshar, JJ Liang, A Sharma… - Authorea …, 2022 - essopenarchive.org
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has
caused many complications, the invention of coronavirus disease 2019 (Covid-19) vaccines …

[PDF][PDF] The fight against COVID‐19 on the multi‐protease front and surroundings: could an early therapeutic approach with repositioning drugs prevent the disease …

A Vianello, S Del Turco, S Babboni, B Silvestrini… - 2021 - academia.edu
The interaction between the membrane spike (S) protein of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) and the transmembrane angiotensin-converting …